Live-attenuated HIV vaccines: How safe is safe enough?

1. Warren, J.T. & Levinson, M.A. Fourth annual survey of worldwide HIV, SIV, and SHIV challenge studies in vaccinated nonhuman primates. J. Med. Primatol. 24, 150−168 (1995). | PubMed  | ISI | ChemPort |
2. Daniel, M.D., Kirchhoff, F., Czajak, S.C., Sehgal, P.K. & Desrosiers, R.C. Protective effects of a live-attenuated SIV vaccine with a deletion in the nef gene. Science 258, 1938−1941 (1992). | PubMed  | ISI | ChemPort |
3. Wyand, M.S., Manson, K.H., Garcia-Moll, M., Montefiori, D. & Desrosiers, R.C. Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J. Virol. 70, 3724 (1996). | PubMed  | ISI | ChemPort |
4. Clements, J.E. et al. Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus. J. Virol. 69, 2737−2744 (1995). | PubMed  | ISI | ChemPort |
5. Lohman, B.L. et al. A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge. J. Virol. 68, 7021−7029 (1994). | PubMed  | ISI | ChemPort |
6. Baba, T.W. et al. Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science 267, 1820−1825 (1995). | PubMed  | ISI | ChemPort |
7. Gibbs, J.S., Regier, D.A. & Desrosiers, R.C. Construction and in vitro properties of SIVmac mutants with deletions in the "nonessential" genes. AIDS Res. Hum. Retroviruses 10, 607−616 (1994). | PubMed  | ISI | ChemPort |
8. Wyand, M., Manson, K.H., Lackner, A.A. & Desrosiers, R.C. Resistance of neonatal monkeys to live-attenuated vaccine strains of simian immunodeficiency virus. Nature Med. 3, 32−36 (1997). | Article | PubMed  | ISI | ChemPort |

	Top

	Top